Latest Observability News

Catalina Resources has strengthened its cash position through a strategic asset sale and is progressing drilling programs targeting gold and rare earth elements in Western Australia.

Australian Vintage Ltd is accelerating its inventory reduction by exiting the Millewa Vineyard lease early, unlocking over $8 million in net cash flow benefits and reshaping its grape sourcing strategy.

Kinterra Capital has lodged a formal review application against the Takeovers Panel’s earlier ruling involving New World Resources, signaling potential shifts in the ongoing corporate governance saga.

Catalina Resources has launched a reverse circulation drilling campaign at its Laverton project, aiming to extend high-grade rare earth and gold mineralisation just 2km from the Mt Weld mine. The program seeks to confirm structural links to one of the world’s richest rare earth deposits.

Terrain Minerals has wrapped up an expanded nearly 5,000-meter gold drilling campaign at its Lightning and Monza prospects within the Smokebush Project, with assay results expected in August 2025.

Australian Bond Exchange Holdings has joined a Reserve Bank of Australia-led pilot exploring atomic settlement of tokenised bonds using digital currencies, aiming to transform bond market infrastructure.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.

Antares Metals has identified a significant 450-metre copper mineralised vein system near Conglomerate Creek, bolstering the potential for a large-scale copper deposit at its Mt Isa North project in Queensland.

Tamboran Resources has reported a record-breaking 60-day initial production flow rate of 6.8 million cubic feet per day from its Shenandoah South 2H sidetrack well in the Beetaloo Basin, underscoring its progress toward commercial gas supply for Northern Australia.

Nyrada has initiated the last cohort of its Phase I trial for Xolatryp, following a clean safety review of the highest dose tested so far. This step sets the stage for critical data that could shape the drug’s next development phase.

Unico Silver Limited has reported a breakthrough drill intercept at its La Negra prospect, significantly extending mineralisation beyond previous estimates and bolstering its PLUS 150 growth strategy.

Imugene Limited reports promising Phase 1b trial results for azer-cel, an off-the-shelf CAR T therapy, showing a 75% overall response rate in relapsed diffuse large B-cell lymphoma patients. The company plans to engage the FDA later this year to discuss pivotal trial design.